January 23
2022
download app
download appDOWNLOAD OUR APP
download google-play
download app-store
Anjum Shabbir
share
31st January 2020
Consumer, Health & Environment Internal Market

Marketing authorisations for medicinal products in December 2019

Two summaries of EU decisions on marketing authorisations in respect of medicinal products from 1 December to 31 December 2019 were published in the Official Journal today.

On the one hand, publication was made of several decisions taken pursuant to Articles 13 and 38 of Regulation 726/204, including decisions to issue eight marketing authorisations, to modify 77, to reject one, and to withdraw three. The full list is available here.

On the other hand, publication was made of the decision to grant national market authorisations for the medicinal product ‘Flurbiprofen’, regarding Czechia, The Netherlands, Portugal, Slovakia, and Spain, to the company Geiser Pharma, S.L. Read it here.

×

Your privacy is important for us

We use cookies to improve the user experience. Please review privacy preferences.

Accept all Settings

Check our privacy policy and cookies policy.

Cookies